StonvexLoading…
StonvexStonvexStonvexCore line items from RNW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | $1.14B | $976.00M | $1.09B | $912.00M |
Operating Income | $118.00M | $100.00M | $-31.00M | $-161.00M |
Net Income | $54.00M | $50.00M | $-61.00M | $-213.00M |
EPS (Diluted) | $0.13 | $0.12 | $-0.15 | $-0.54 |
Total Assets | $11.23B | $10.49B | $9.08B | $8.45B |
Total Liabilities | $9.70B | $9.03B | $7.64B | $6.79B |
Cash & Equivalents | $473.00M | $316.00M | $458.00M | $345.00M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 362.77M | 362.63M | 373.04M | 399.18M |